Welcome Kael Reicin, our new CFO at the 23andMe Research Institute. Kael’s leadership will help us grow our impact and bring the promise of genetics to everyone. Read more here: https://t.co/5VIMS4lV6O

Welcome Peggy Bodin, Fred Cate, and @zittrain to the 23andMe Research Institute Privacy Advisory Board. These leading experts in health data privacy, data ethics, and consumer advocacy, will provide strategic guidance on the protection of member information and the

We are pleased to announce the appointment of @BradMargus and @StephenQuake to the 23andMe Research Institute Board of Directors. Both bring exceptional scientific and leadership experience that will help guide our mission to accelerate genetic research and expand access to

We are proud to share that 23andMe has been named to the TIME's Best Inventions Hall of Fame! A big thank you to @TIME for this honor and to our 23andMe community for shaping the future of genetics and research. 🧬 🌎 https://t.co/rYjDcH5wX4

60% of depression patients don’t respond to their first treatment, and one in three face treatment-resistant depression (TRD). A new study from J&J + 23andMe shows AI can predict TRD risk with 78% accuracy—using only self-reported data. Hope for faster, more tailored care:

New study from 23andMe + Dana-Farber: Breast cancer patients with higher genetic risk scores actually lived longer, on average, than those with lower scores. Why? Still unknown — but it suggests inherited cancers may progress more slowly than those driven by environmental

A massive new genetic study of dyslexia using data from the 23andMe Research Institute uncovered dozens of previously unknown genetic factors linked to the condition that affects between 5-10% of school-age children. Many of the genetic associations play a role in early brain

The largest genetic study of stuttering, powered by more than 1 million 23andMe research participants, is shining light on this poorly understood condition that affects more than 400 million people worldwide. Read more about this groundbreaking work here:

We’re teaming up with Troper Wojcicki Philanthropies and @lifebitAI to launch an open-access platform for lung cancer research - one of the most diverse lung cancer cohorts ever assembled. FREE for qualified researchers. Get details here: https://t.co/hsekVaAf85

TTAM Research Institute, a nonprofit public benefit corporation, has completed the acquisition of 23andMe assets. As part of TTAM, 23andMe is continuing to operate, and TTAM is committed to providing customers with choice and transparency with their data. Read more here:

23andMe announced a new definitive agreement to be acquired by TTAM Research Institute. TTAM has committed to complying with the Company’s privacy policy and all applicable law and to adopting additional consumer protections and privacy safeguards to enhance protections for

We have reached a sale agreement with @Regeneron, a leading US-based biotechnology company, to carry forward 23andMe’s mission and maintain customer privacy protections. Read more about today’s announcement here:

We believe in the strength of what we’ve built and believe today's announcement will enable 23andMe to emerge a more financially stable organization. We remain open for business, and there are no changes to the way we store, manage or protect customer data. For more details,

MTHFR is the most asked-about gene by 23andMe customers, but MTHFR results alone don’t yield much actionable information. But pairing it with a homocysteine-specific blood test gives a more complete picture – and a starting point for action. Read more about our new report & lab

We’ve added 44 new Genetic Groups across India, Pakistan, Sri Lanka, Bangladesh, Nepal, and Afghanistan! South Asia is incredibly diverse, and now you can explore even deeper ancestral connections in your 23andMe results. Check out the details here:

Just launched: New 23andMe+ Premium Report: Osteoporosis Genetics accounts for ~ 60-80% of the variability in bone density. Osteoporosis is common, but early awareness = action! Learn how genetics may impact your bone health & what you can do about it. 🔗 Read more:

Jill Feldman, Lung Cancer Patient, Advocate and Co-Founder @EGFRResisters penned a powerful article in CURE magazine on the importance of 23andMe’s Lung Cancer Genetics Study. https://t.co/fsmOLPF43n “The partnership between 23andMe and the lung cancer community marks a shift

New landmark study led by @EdinburghUni and @KingsCollegeLon looking at genomes of 5M+ people across 29 countries — including 23andMe customers who consented to participate in research — uncovered ~300 previously unknown genetic links to depression.

Research has always been in our DNA! Excited that @lifebitAI will be helping power Discover23® to help researchers bring new and more effective treatments to the people who need them. https://t.co/CoSMccTFmP #discover23

Check out the first blog post – in a series – where we hope to amplify further awareness of lung cancer, in partnership with the 20+ lung cancer patient advocacy organizations helping contribute to our ongoing Lung Cancer Genetics Study https://t.co/UXDFag88b3